Lupin signs deal with Axantia to market pegfilgrastim in Middle East and Africa
Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy
Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy
G42 Healthcare and AstraZeneca will work closely together to explore real-world evidence and conduct clinical trials through IROS – the first-of-its-kind Contract Research Organization (CRO) in the UAE
The proposed scheme to include low-income NRIs under Ayushman Bharat (PM-JAY) would ensure life-long coverage for each individual along with their spouses
The campaign “Care is Just An Aster Away” was launched along with the unveiling of the new corporate logo on Burj Khalifa on 11th December
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Acute therapies continue to report strong growth compared to chronic ones.
Key takeaways of recent quarter & conference call highlights
The division is expected to grow to over a 100-member strong team by 2022
Subscribe To Our Newsletter & Stay Updated